FirstWord Group
@firstwordgroup.com
FirstWord is a global leader in news and intelligence for the Pharma and MedTech industries. Find our services here www.firstwordpharma.com, www.firstwordhealthtech.com, and www.firstwordreports.com
Daiichi's ADC optimism after safety flag $DSNKY $MRK #JPM26 firstwordpharma.com/story/7064917
January 15, 2026 at 4:15 AM
Daiichi's ADC optimism after safety flag $DSNKY $MRK #JPM26 firstwordpharma.com/story/7064917
J&J touts another Phase III success for Tecvayli in earlier myeloma $JNJ firstwordpharma.com/story/7064828
January 15, 2026 at 4:15 AM
J&J touts another Phase III success for Tecvayli in earlier myeloma $JNJ firstwordpharma.com/story/7064828
Ultrahuman and Click Therapeutics merge biometrics with migraine DTx firstwordhealthtech.com/story/7064706
January 14, 2026 at 11:51 PM
Ultrahuman and Click Therapeutics merge biometrics with migraine DTx firstwordhealthtech.com/story/7064706
As pharma bets big on AI, regulators set some ground rules firstwordpharma.com/story/7064685
January 14, 2026 at 10:09 PM
As pharma bets big on AI, regulators set some ground rules firstwordpharma.com/story/7064685
Novo Nordisk, Eli Lilly trade blows on oral obesity aspirations $NVO $LLY #JPM26 firstwordpharma.com/story/7063783
January 14, 2026 at 1:09 PM
Novo Nordisk, Eli Lilly trade blows on oral obesity aspirations $NVO $LLY #JPM26 firstwordpharma.com/story/7063783
Novo Nordisk's new CEO makes his pitch $NVO #JPM26 firstwordpharma.com/story/7063440
January 14, 2026 at 1:19 AM
Novo Nordisk's new CEO makes his pitch $NVO #JPM26 firstwordpharma.com/story/7063440
Biopharma bites: Menkes milestone, Oricell fuels CAR-T, ACIP adds two members… and more $NVS $ZYDUSLIFE firstwordpharma.com/story/7063576
January 14, 2026 at 1:19 AM
Biopharma bites: Menkes milestone, Oricell fuels CAR-T, ACIP adds two members… and more $NVS $ZYDUSLIFE firstwordpharma.com/story/7063576
Ro, Amgen probe insurance roadblocks to GLP-1 care $AMGN firstwordpharma.com/story/7063469
January 14, 2026 at 1:18 AM
Ro, Amgen probe insurance roadblocks to GLP-1 care $AMGN firstwordpharma.com/story/7063469
Illumina charts billions of human cells to advance AI drug discovery $ILMN firstwordpharma.com/story/7063468
January 14, 2026 at 1:17 AM
Illumina charts billions of human cells to advance AI drug discovery $ILMN firstwordpharma.com/story/7063468
FDA moves to strip suicide warnings from GLP-1 labels $NVO $LLY firstwordpharma.com/story/7063390
January 14, 2026 at 1:16 AM
FDA moves to strip suicide warnings from GLP-1 labels $NVO $LLY firstwordpharma.com/story/7063390
AstraZeneca brings Modella AI in-house to power oncology R&D $AZN firstwordpharma.com/story/7063307
January 14, 2026 at 1:16 AM
AstraZeneca brings Modella AI in-house to power oncology R&D $AZN firstwordpharma.com/story/7063307
Senate committee targets biotech bottlenecks to maintain US edge firstwordpharma.com/story/7062895
January 14, 2026 at 1:15 AM
Senate committee targets biotech bottlenecks to maintain US edge firstwordpharma.com/story/7062895
Neurolief wins FDA PMA approval for at-home depression neuromodulation device
firstwordhealthtech.com/story/7061303
firstwordhealthtech.com/story/7061303
January 13, 2026 at 2:50 PM
Neurolief wins FDA PMA approval for at-home depression neuromodulation device
firstwordhealthtech.com/story/7061303
firstwordhealthtech.com/story/7061303
Rebranded AI biotech Proxima lands $80M to scale proximity-based therapeutics firstwordpharma.com/story/7062570
January 13, 2026 at 1:44 PM
Rebranded AI biotech Proxima lands $80M to scale proximity-based therapeutics firstwordpharma.com/story/7062570
AbbVie pledges $100B in US investment to avoid Trump tariffs firstwordpharma.com/story/7062076
January 13, 2026 at 10:37 AM
AbbVie pledges $100B in US investment to avoid Trump tariffs firstwordpharma.com/story/7062076
'It's like Viagra' — Bourla lays out Pfizer's commercial obesity strategy $PFE $NVO $LLY #JPM26 firstwordpharma.com/story/7061364
January 12, 2026 at 10:53 PM
'It's like Viagra' — Bourla lays out Pfizer's commercial obesity strategy $PFE $NVO $LLY #JPM26 firstwordpharma.com/story/7061364
Sanofi maintains long-term view on vaccines despite 'sensitivity' of US administration $SNY #JPM26 firstwordpharma.com/story/7060965
January 12, 2026 at 9:50 PM
Sanofi maintains long-term view on vaccines despite 'sensitivity' of US administration $SNY #JPM26 firstwordpharma.com/story/7060965
Biopharma bites: Teva, Kinaset pull in funds, Camzyos wins in teens, plus contrasting fortunes for Lynk, Lyra $TEVA $BMY $LYRA firstwordpharma.com/story/7061231
January 12, 2026 at 9:49 PM
Biopharma bites: Teva, Kinaset pull in funds, Camzyos wins in teens, plus contrasting fortunes for Lynk, Lyra $TEVA $BMY $LYRA firstwordpharma.com/story/7061231
Atara, Pierre Fabre call out FDA U-Turn in second snub for Ebvallo $ATRA firstwordpharma.com/story/7059888
January 12, 2026 at 9:48 PM
Atara, Pierre Fabre call out FDA U-Turn in second snub for Ebvallo $ATRA firstwordpharma.com/story/7059888
illy, NVIDIA pour $1B in AI lab to accelerate drug discovery $LLY $NVDA #JPM26 firstwordpharma.com/story/7059674
January 12, 2026 at 9:47 PM
illy, NVIDIA pour $1B in AI lab to accelerate drug discovery $LLY $NVDA #JPM26 firstwordpharma.com/story/7059674
FDA lifts partial hold on Daiichi, Merck & Co.'s ADC lung cancer study $DSNKY $MRK firstwordpharma.com/story/7058226
January 12, 2026 at 9:46 PM
FDA lifts partial hold on Daiichi, Merck & Co.'s ADC lung cancer study $DSNKY $MRK firstwordpharma.com/story/7058226
Novartis bets up to $1.7B on SciNeuro's brain shuttle in Alzheimer's push $NVS firstwordpharma.com/story/7058163
January 12, 2026 at 9:45 PM
Novartis bets up to $1.7B on SciNeuro's brain shuttle in Alzheimer's push $NVS firstwordpharma.com/story/7058163
JPM26: Lilly, NVIDIA pour $1B in AI lab to accelerate drug discovery $LLY $NVDA #JPM26 firstwordhealthtech.com/story/7059674
January 12, 2026 at 8:36 PM
JPM26: Lilly, NVIDIA pour $1B in AI lab to accelerate drug discovery $LLY $NVDA #JPM26 firstwordhealthtech.com/story/7059674
AbbVie pays $650M upfront for rights to RemeGen's PD-1/VEGF bispecific #JPM26 firstwordpharma.com/story/7058073
January 12, 2026 at 1:32 PM
AbbVie pays $650M upfront for rights to RemeGen's PD-1/VEGF bispecific #JPM26 firstwordpharma.com/story/7058073
Sanofi's Teizeild approved in EU to delay onset of type 1 diabetes firstwordpharma.com/story/7057996
January 12, 2026 at 12:53 PM
Sanofi's Teizeild approved in EU to delay onset of type 1 diabetes firstwordpharma.com/story/7057996